Your Notifications
All done, no notifications

Castleman Disease Treatment Cost in United Kingdom

USD 10000 - USD 60000

Affordable World-class Treatment - Accredited Hospitals - Free Treatment Plan in 24 Hrs

2
Days in Hospital
2-6 hrs
Procedure Time
70 - 95%
Success Rate
Get Free Treatment Plan Connect with an Expert
JCI/ISO 100,000+ Patients 24X7 Coordinator Visa & Travel handled
Your all-in-one medical travel platform for treatment, recovery & care.

Get Your Personalised Treatment Plan in Just 24 Hours.

Share your details to receive a personalised treatment plan, estimated costs, hospital recommendations, and expert guidance, “completely free.”

Required | alphabets and spaces
Required | A valid, working email address
Required | A valid contact
Connect with an Expert

Your information is protected with HIPAA-compliant security standards. We only share your details with hospitals after your consent.

Estimated Treatment Cost
USD 10000 - USD 60000
All-inclusive • Hospital + Medications + Recovery Assistance + Dedicated Care Coordinator
International Quality. Affordable Care.

What's included in your Castleman Disease Treatment quote?

Castleman disease treatment
consultation, plan, therapy, hospital charges
Hematology & oncology consultations
Pre evaluation, treatment planning, follow-ups
2–7-day hospital stay
management
7–14-day in-country follow-up
Treatment response assessment
Visa & medical-visa invite letter
Airport pickup & transfers
Get Itemized Quote FREE

Cost of Castleman Disease Treatment in Major Cities of United Kingdom

CityCost (USD)
Cheadle $22,500 – $45,000 Explore More
London $25,000 – $50,000 Explore More
Wales $25,000 – $50,000 Explore More

Castleman Disease Treatment - United Kingdom Vs the World

Malaysia
$2k - $11k
United Arab Emirates
$3k - $4k
South Korea
$4k - $6k
Singapore
$5k - $0
India
$7k - $20k
Italy
$8k - $25k
Vietnam
$8k - $15k
Spain
$11k - $44k
Turkey
$12k - $25k
Saudi Arabia
$18k - $40k
Thailand
$18k - $40k
Israel
$25k - $50k
United Kingdom
$25k - $50k
Tanya Bose
Author

Tanya Bose

MSc Biotechnology

4 Years of Experience

Tanya Bose is a medical content specialist with a strong medical background. She has completed her Bachelor's and Master’s in Biotechnology from Amity University. With a deep understanding of biomedical sciences and research, she develops authoritative and patient-focused medical content covering treatments, surgical procedures, and healthcare innovations. Her writing emphasizes accuracy, clarity, and evidence-based information to help readers better understand complex medical topics. She is dedicated to improving patient awareness and supporting informed healthcare decisions by delivering trustworthy medical insights in a clear and accessible format.
View More
Dr Prateek Varshney
Reviewer

Dr Prateek Varshney

Surgical Oncologist

15 Years of Experience

Last Reviewed - June 2026

Dr. Prateek Varshney is a renowned Surgical Oncologist. He has experience of more than 15+ years in surgical Oncology. He is currently practicing as a consultant at Metro Mass Hospital and Cancer Institute. He was also previously associated as a consultant with Sir Ganga Ram Hospital and as a professor at Gujarat Cancer Research Institute.
View More

Need Help Choosing the Right Treatment? Talk to a Medical Advisor

Our dedicated Medical Patient Advisors are here to answer your questions, help you compare treatment options, estimate costs, and guide you through every step of your healthcare journey.

Connect with an Expert Request a Free Consultation
15 min
Average response time
Serving Patients Worldwide in Multiple Languages.

Castleman disease is a group of rare disorders characterized by enlarged lymph nodes and a wide range of symptoms. The most common form of the disorder involves a single enlarged lymph node, typically found in the chest or neck, but it can occur in other areas of the body as well. This form is known as Unicentric Castleman Disease (UCD).

Multicentric Castleman Disease (MCD), on the other hand, involves multiple regions of enlarged lymph nodes, along with inflammatory symptoms and problems with organ function.

Explore Hospitals ( 4 )

Wales, United Kingdom

89+ Beds · 59+ Procedures
Starting
USD 22000

London, United Kingdom

234+ Beds · 425+ Procedures
JCI
Starting
USD 35000

London, United Kingdom

80+ Procedures
Starting
USD 10000

Cheadle, United Kingdom

183+ Procedures
NABH
Starting
USD 18000

Get Your Castleman Disease Treatment
Plan in 24 hrs.

Our experienced Medical Patient Advisors have supported 100,000+ patients across 120+ countries with personalised treatment plans, hospital recommendations, cost estimates, and travel assistance, all free.

HIPAA-Compliant Data SecurityShared Only with Your Consent

✓ Free Consultation ✓ No Obligation ✓ Personalized Treatment Plan ✓ Response Within 24 Hours

Required | alphabets and spaces
Required | A valid, working email address
Required | A valid contact

Your medical info is kept HIPAA-style confidential. We never share with hospitals without your consent.

Jenny Wilson
Your Dedicated Medical Patient Advisor
Treatment planning • Hospital coordination • Multilingual support • Response within 15 minutes.
Connect with an Expert Book 15-min call
Our Services to Better your Experience

Opinion & Option

We submit the most accurate opinion and options from one or more countries for your review

Consult Privately

Consult with a certified specialist privately on our telemedicine platform even before you decide to travel

Logistics

We handle flights, visas, transfers, and accommodation—so you can focus on your health.

Recovery

Our In-house rehabilitation service packages to better your recovery and treatment outcome

Patient Stories

Ms. Monica
Ms. Monica
Monica from Ghana for AV Malformation Treatment in India

Monica from Ghana suffered from AV malformation. She decided to look for options for medical treatment when she started experiencing…

Watch Story
Silim Shabani
Silim Shabani
Patient Testimonial: Silim Shabani for Ovarian Cancer Treatment in Turkey

Nasrin (Sister of the patient ) explains the journey of how MediGence helped for the treatment of Silim Shabani for…

Watch Story

Frequently Asked Questions

The cost of Castleman disease treatment in United Kingdom may vary depending on the type of disease, the number and location of affected lymph nodes, the treatment approach, hospital charges, specialist fees, and the need for surgery, medicines, or long-term monitoring. The overall cost may include diagnostic tests, imaging, biopsy, hospitalisation, medications, specialist consultations, supportive care, and follow-up visits.MediGence can help international patients explore suitable hospitals and obtain an estimated treatment plan based on their diagnosis and medical requirements.

The best hospitals for Castleman disease treatment in United Kingdom are those with experienced haematologists, medical oncologists, pathologists, surgeons, and multidisciplinary teams familiar with rare lymphoproliferative disorders. Patients should consider hospitals with advanced diagnostic facilities, specialised haematology and oncology services, intensive care support, and access to targeted or immunomodulatory therapies.

Patients should seek care from a haematologist or medical oncologist experienced in diagnosing and managing Castleman disease. Depending on the disease type and treatment plan, the care team may also include a pathologist, surgeon, infectious disease specialist, or other specialists.Important factors include the doctor’s qualifications, experience with rare blood and lymph node disorders, expertise in interpreting pathology findings, hospital affiliation, and ability to explain the diagnosis, treatment options, expected outcomes, and possible risks.

Treatment outcomes depend on the type of Castleman disease, the extent of lymph node involvement, associated conditions, the patient’s overall health, and response to therapy. Unicentric Castleman disease may often be effectively treated with complete surgical removal of the affected lymph node or mass. Multicentric Castleman disease usually requires systemic treatment and long-term monitoring.The treating specialist can provide a more individualised outlook after reviewing the patient’s pathology results, imaging findings, laboratory tests, and clinical condition.

Hospitals in United Kingdom may use advanced imaging, including CT, MRI, and PET scans, along with lymph node biopsy, histopathological examination, immunohistochemistry, blood tests, and specialised laboratory assessments.Treatment may involve surgical removal of localised disease, monoclonal antibody therapy, immunotherapy, corticosteroids, chemotherapy, antiviral treatment in selected cases, or supportive care. A multidisciplinary team determines the most appropriate treatment plan based on the type and severity of the disease.

The risks and complications depend on the disease type and treatment approach. Possible complications may include:
  • Bleeding, infection, or injury to nearby structures after surgery
  • Infusion-related or allergic reactions
  • Reduced immunity and an increased risk of infection
  • Fatigue, nausea, or other treatment-related side effects
  • Low blood cell counts
  • Organ dysfunction in severe cases
  • Disease recurrence or progression
  • Need for long-term treatment and monitoring
    • The treating team will explain the potential risks based on the patient’s condition and planned treatment.

    Before travelling, patients should undergo a detailed medical evaluation and share all relevant records with the treating haematology or oncology team. These may include lymph node biopsy and pathology reports, CT, MRI, or PET scan results, blood test findings, previous treatment records, and details of current medications and allergies.Patients should also discuss the expected treatment duration, hospital stay, caregiver requirements, and follow-up plan before making travel arrangements.

    Yes. International patients can arrange an online consultation with a haematologist or medical oncologist before travelling to United Kingdom. The specialist may review pathology reports, imaging findings, laboratory results, medical history, and previous treatments to recommend further evaluation or an appropriate treatment approach.MediGence can help coordinate online consultations and facilitate the sharing of relevant medical records with suitable specialists.

    International patients should carry a valid passport and all relevant medical documents, including:
  • Lymph node biopsy and pathology reports
  • Immunohistochemistry or specialised laboratory reports, if available
  • CT, MRI, PET, or other imaging reports
  • Recent blood test results
  • Previous treatment or surgical records
  • Current prescriptions and medication details
  • Allergy and medical history records

    • The required stay in United Kingdom depends on the type and extent of Castleman disease, the treatment approach, response to therapy, and follow-up requirements. Patients undergoing surgery for localised disease may require a shorter stay, while those receiving systemic therapy may need a longer or repeated stay. The treating team will recommend an appropriate timeline based on the individual treatment plan.

    Recovery varies according to the treatment received. Recovery after surgery may take several weeks, while systemic therapy may require ongoing treatment and monitoring over a longer period. Patients may need regular blood tests, imaging, medication adjustments, and supportive care during recovery.

    If complications occur, patients should contact the treating haematology or oncology team or seek prompt medical attention. Urgent evaluation may be required for high fever, severe weakness, breathing difficulty, unusual bleeding, persistent vomiting, signs of infection, or sudden worsening of symptoms.Patients should receive clear discharge instructions and a follow-up plan before returning home.

    International patients can begin by submitting their medical details and relevant reports through the MediGence website. After an initial review, the MediGence care team can help patients explore suitable hospitals and specialists, coordinate consultations, and support treatment planning and medical travel arrangements.The final treatment recommendation is made by the treating haematology or multidisciplinary care team after a detailed clinical evaluation.

    International patients may choose United Kingdom for access to experienced haematologists and oncologists, specialised centres for rare diseases, advanced diagnostic facilities, and comprehensive treatment services. The destination should be evaluated based on clinical expertise, access to appropriate therapies, patient safety standards, and the availability of long-term follow-up care.

    Treatment options depend on whether the disease is unicentric or multicentric, the extent of lymph node involvement, associated conditions, and the patient’s overall health. Depending on the diagnosis, options may include:
  • Surgical removal of the affected lymph node or mass
  • Monoclonal antibody therapy
  • Immunomodulatory treatment
  • Corticosteroids
  • Chemotherapy in selected cases
  • Antiviral treatment when clinically indicated
  • Supportive care and long-term monitoring
    • The treating specialist will recommend the most suitable treatment plan after reviewing the patient’s diagnostic findings.

    International patients may choose United Kingdom for access to specialised haematology and oncology centres, experienced multidisciplinary teams, advanced diagnostic services, and comprehensive treatment and follow-up care.MediGence can assist international patients with hospital and specialist selection, medical report coordination, consultation scheduling, treatment planning, and travel-related support. The final destination should be selected according to the patient’s diagnosis, treatment needs, and the hospital’s expertise in managing Castleman disease.

    Not Sure About Your Treatment Plan? Get a Free Second Opinion

    Have your reports reviewed by independent oncology experts to help you make a confident treatment decision, all online within 48 hours.

    Upload Your Reports
    Free second opinion on your CAR-T plan